Home > Insider Trading > Filing (0001127602-22-022683)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
313143	Haemonetics Corp	HAE	Surgical & Medical Instruments & Apparatus (3841)	042882273

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1699629	L Michelle Basil	125 Summer Street Boston MA 02110	Evp And General Counsel	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2022-09-15	11,154	$38.43	51,789	No	4	M	Direct
Common Stock	Acquisiton	2022-09-15	14,231	$41.64	66,020	No	4	M	Direct
Common Stock	Acquisiton	2022-09-15	3,173	$56.57	69,193	No	4	M	Direct
Common Stock	Disposition	2022-09-15	27,769	$77.76	41,424	No	4	S	Direct
Common Stock	Disposition	2022-09-15	6,029	$78.50	35,395	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-qualified Stock Option (Right to Buy)	Disposition	2022-09-15	11,154	$0.00	11,154	$38.43
Common Stock	Non-qualified Stock Option (Right to Buy)	Disposition	2022-09-15	14,231	$0.00	14,231	$41.64
Common Stock	Non-qualified Stock Option (Right to Buy)	Disposition	2022-09-15	3,173	$0.00	3,173	$56.57

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
3,464	2018-03-06	2024-03-06	No	4	M	Direct
4,213	2018-06-06	2024-06-06	No	4	M	Direct
13,564		2028-05-18	No	4	M	Direct

Footnotes

Transaction pursuant to an existing 10b5-1 trading plan.
This number includes unvested restricted stock units ("RSUs") previously reported.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.33 to $78.30, inclusive. The reporting person undertakes to provide to Haemonetics Corporation ("Haemonetics"), any security holder of Haemonetics, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3) and (4) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.33 to $78.85, inclusive.
Option vests in annual increments of 25% beginning on the first anniversary of the date of grant.